summary
Introduced
07/23/2019
07/23/2019
In Committee
09/09/2020
09/09/2020
Crossed Over
11/18/2020
11/18/2020
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
Block, Report, And Suspend Suspicious Shipments Act of 2020 Block, Report, And Suspend Suspicious Shipments Act of 2020 This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances. In addition to reporting the suspicious order to the Drug Enforcement Administration, a manufacturer or distributor must also exercise due diligence and decline to fill the order.
AI Summary
This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances. In addition to reporting the suspicious order to the Drug Enforcement Administration (DEA), the bill requires them to exercise due diligence and decline to fill the order if the due diligence fails to resolve all indicators that filling the order would cause a violation of the Controlled Substances Act. The bill directs the Attorney General to promulgate regulations specifying the indicators that give rise to a suspicion that filling an order would cause a violation. The new requirements will take effect one year after the bill's enactment.
Committee Categories
Business and Industry, Health and Social Services, Justice, Military Affairs and Security
Sponsors (4)
Last Action
Received in the Senate and Read twice and referred to the Committee on the Judiciary. (on 11/18/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...